Premium
Response to ‘Phase IV head‐to‐head randomized controlled trial comparing ingenol mebutate 0·015% gel with diclofenac sodium 3% gel for the treatment of actinic keratosis on the face or scalp’: reply from the authors
Author(s) -
Stockfleth E.,
Harwood C.A.,
SerraGuillén C.,
Larsson T.,
Østerdal M.L.,
Skov T.
Publication year - 2018
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/bjd.16225
Subject(s) - actinic keratosis , dermatology , medicine , scalp , diclofenac sodium , diclofenac , randomized controlled trial , surgery , anesthesia , pharmacology , basal cell